SAN.PA: Summary for SANOFI - Yahoo Finance

UK Markets open in 4 hrs 11 mins

Sanofi (SAN.PA)


Paris - Paris Delayed price. Currency in EUR
Add to watchlist
75.77-0.73 (-0.95%)
At close: 5:35PM CET
People also watch
FP.PABN.PACS.PAOR.PAAI.PA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous close76.50
Open76.54
Bid71.12 x 1000
Ask71.74 x 44000
Day's range75.38 - 76.69
52-week range62.50 - 79.07
Volume2,026,228
Avg. volume2,912,339
Market cap95.13B
Beta0.74
PE ratio (TTM)23.25
EPS (TTM)N/A
Earnings dateN/A
Dividend & yield3.35 (4.05%)
Ex-dividend dateN/A
1y target estN/A
  • The Wall Street Journal7 hours ago

    [$$] Rival to EpiPen Allergy Treatment to Return to Market

    The maker of an EpiPen rival said its emergency allergy treatment would return to the market on Feb. 14, adding more competition to the market for the costly products.

  • Reuters - UK Focus18 hours ago

    GSK grabs Astra executive to replace pharma head

    LONDON/DAVOS, Switzerland, Jan 19 (Reuters) - G laxoSmithKline's global head of pharmaceuticals, Abbas Hussain, is to leave Britain's biggest drugmaker after being passed over for the top job and will be replaced by Luke Miels from AstraZeneca. Hussain, the brother of former England cricket captain Nasser Hussain, had been a contender to take over from Chief (Taiwan OTC: 3345.TWO - news) Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health boss Emma Walmsley.

  • The Wall Street Journalyesterday

    [$$] Mallinckrodt Settles Antitrust Allegations on Unlawful Drug Monopoly

    Irish drugmaker Mallinckrodt and a U.S. subsidiary will pay $100 million and agree to other conditions to settle government antitrust allegations they unlawfully prevented competition for Acthar, a drug ...